Evidence map›Paper›PMID 20100701›Full record

ArticleHuman reproduction (Oxford, England)2010

Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol.

D S Johnson, G Gemelos, J Baner, A Ryan, C Cinnioglu, M Banjevic, R Ross, M Alper, B Barrett, J Frederick and 3 more

Open access · bronzeAbstract readComparative StudyEvaluation StudyValidation Study
In one paragraph

Article in Human reproduction (Oxford, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
56.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 278 citations in OpenAlex.

  1. Pooled it
  2. The number of biopsied trophectoderm cells may affect pregnancy outcomes.Journal of assisted reproduction and genetics · 2019
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Preimplantation genetic testing for aneuploidy: The management of mosaic embryos.Clinical and experimental reproductive medicine · 2022
    Article
  16. Article
  17. Haplotype-aware inference of human chromosome abnormalities.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

D S JohnsonGene Security Network, Inc., 2686 Middlefield Road, Suite C, Redwood City, CA 94063, USA. djohnson@genesecurity.net
G Gemelos
J Baner
A Ryan
C Cinnioglu
M Banjevic
R Ross
M Alper
B Barrett
J Frederick
D Potter
B Behr
M Rabinowitz
Boston IVF · USStanford University · USLa Jolla Alcohol Research · USStanford Medicine · USSUNY Geneseo · US

Funding

Novel Informatics for Highly Reliable Multi-Locus Allele Calling for Embryo ScreeR44HD054958 · NICHD · NATERA, INC. · PI RABINOWITZ, MATTHEW · 2008 to 2009
$1.5M
NICHD NIH HHS 2R44HD054958
6 · The paper itself

Abstract

backgroundPreimplantation genetic screening (PGS) has been used in an attempt to determine embryonic aneuploidy. Techniques that use new molecular methods to determine the karyotype of an embryo are expanding the scope of PGS.

methodsWe introduce a new method for PGS, termed 'parental support', which leverages microarray measurements from parental DNA to 'clean' single-cell microarray measurements on embryonic cells and explicitly computes confidence in each copy number call. The method distinguishes mitotic and meiotic copy errors and determines parental source of aneuploidy.

resultsValidation with 459 single cells of known karyotype indicated that per-cell false-positive and false-negative rates are roughly equivalent to the 'gold standard' metaphase karyotype. The majority of the cells were run in parallel with a clinical commercial PGS service. Computed confidences were conservative and roughly concordant with accuracy. To examine ploidy in human embryos, the method was then applied to 26 disaggregated, cryopreserved, cleavage-stage embryos for a total of 134 single blastomeres. Only 23.1% of the embryos were euploid, though 46.2% of embryos were mosaic euploid. Mosaicism affected 57.7% of the embryos. Counts of mitotic and meiotic errors were roughly equivalent. Maternal meiotic trisomy predominated over paternal trisomy, and maternal meiotic trisomies were negatively predictive of mosaic euploid embryos.

conclusionsWe have performed a major preclinical validation of a new method for PGS and found that the technology performs approximately as well as a metaphase karyotype. We also directly measured the mechanism of aneuploidy in cleavage-stage human embryos and found high rates and distinct patterns of mitotic and meiotic aneuploidy.

Indexed as

AneuploidyBlastomeresFemaleGenetic TestingHumansKaryotypingMaleMosaicismOligonucleotide Array Sequence AnalysisPregnancyPreimplantation Diagnosis

Identifiers

PMID20100701
PMCPMC2839907
OpenAlexW2158041008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.